Properties
Description
Nilotinib monohydrochloride monohydrate specifically inhibits the activity of the Bcr-Abl tyrosine kinase.
Molecular Formula
C28H25ClF3N7O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Nilotinib monohydrochloride monohydrate targets Bcr-Abl for research in chronic myeloid leukemia therapies.